PeptidePedia The community reference

Talk:Haemoglobin A1c

Discussion page·2 threads·no archives

This article is within the scope of the clinical practice working group.

This is the discussion page for the article Haemoglobin A1c. It is for improving the article: sources, wording, structure, scope and titles. It is not a general discussion forum about the subject, and it is not a place to ask for advice — see Project:Medical disclaimer.

Weighting towards recent weeksResolved

The non-uniform weighting is why people are surprised that a recent change is only partly reflected. Worth the sentence. — A1c_Alder (talk) 09:45, 3 February 2026 (UTC)

And it explains the minimum useful trial duration, which the last section now states. ✓ Done — LabRangeLindy (talk) 13:20, 3 February 2026 (UTC)

Resolved. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.

Variant interferenceDone

A discrepancy between HbA1c and other measures should prompt a question about the assay. That framing is more useful than a list of variants. — TSH_Tallulah (talk) 10:15, 10 May 2026 (UTC)

Agreed, and the alternatives are named for the case where the measure is unreliable. ✓ Done — A1c_Alder (talk) 13:50, 10 May 2026 (UTC)

Done. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.
This page was last edited on 10 May 2026, by A1c_Alder. Text is available under the PeptidePedia Wiki Content Licence (PPCL-BY-SA 4.0).